Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$33.28

0.89 (2.75%)

, TEVA

Teva

$32.78

-0.41 (-1.24%)

13:57
07/14/17
07/14
13:57
07/14/17
13:57

AstraZeneca CEO plans on staying at company, Bloomberg reports

AstraZeneca (AZN) CEO Pascal Soriot plans on staying with the company for the foreseeable future, Bloomberg reports, citing people with knowledge of the matter. Israel's Calcalist reported Wednesday night that Soriot agreed to become the CEO of Teva Pharmaceutical (TEVA).

AZN

AstraZeneca

$33.28

0.89 (2.75%)

TEVA

Teva

$32.78

-0.41 (-1.24%)

  • 19

    Jul

  • 03

    Aug

  • 30

    Aug

AZN AstraZeneca
$33.28

0.89 (2.75%)

07/05/17
SBSH
07/05/17
DOWNGRADE
SBSH
Neutral
GlaxoSmithKline downgraded to Neutral from Buy at Citi
Citi analyst Andrew Baum downgraded GlaxoSmithKline (GSK) to Neutral and lowered his price target for the shares to GBP 17 from GBP 18. The analyst believes the market is underappreciating the slowing of the company's HIV market growth. He prefers shares of AstraZeneca (AZN), Roche (RHHBY) and Bayer (BAYRY) for exposure to Europe.
07/13/17
LEER
07/13/17
NO CHANGE
LEER
Outperform
AstraZeneca CEO departure now would have 'terrible' optics, says Leerink
Leerink analyst Seamus Fernandez said the media report that AstraZeneca (AZN) CEO Pascal Soriot may be leaving the company to take over at Teva (TEVA) comes as a "major surprise," adding that while the company would not comment to him on the rumor it also did not outright deny the report. While the news does not appear to be related to the outcome of the MYSTIC trial in non-small cell lung cancer, the optics around such a departure at this would be "terrible" and his loss would be a "clear negative" for AstraZeneca, according to Fernandez, who has an Outperform rating on Astra shares.
07/13/17
SBSH
07/13/17
NO CHANGE
Target $42
SBSH
Buy
Teva landing Soriot would be 'material positive,' says Citi
Citi analyst Liav Abraham believes Calcalist's report of Teva (TEVA) hiring away AstraZeneca's (AZN) CEO Pascal Soriot has credibility given the "relatively accurate track record" of the Israeli press in the "leaking" of information pertaining to Teva. The news, if confirmed, would be a "material positive" for Teva over the near to medium term, Abraham tells investors in a research note. She believes Soriot would "lend significant credibility" to Teva's turnaround thesis. On the other side, Soriot leaving would increase concerns over the pending outcome of AstraZeneca's MYSTIC trial, which constitutes the dominant near-term driver for the shares, Abraham argues. She has a Buy rating on Teva with a $42 price target. The stock in premarket trading is up 2% to $32.80. AstraZeneca is down 14c to $32.78.
07/14/17
LEER
07/14/17
NO CHANGE
Target $36
LEER
Outperform
Leerink sees significant optionality for AstraZeneca beyond MYSTIC trial
Leerink analyst Seamus Fernandez said he sees significant optionality for AstraZeneca (AZN) beyond the "mega-catalyst" of the MYSTIC trial in non-small cell lung cancer, as he believes several 2017 and 2018 readouts from underappreciated pipeline assets could lead to upside for the shares. If MYSTIC fails, Astra's "massive" SG&A spend gives it flexibility to mute the bottom-line impact. If it is successful, he believes potential acquirers such as Pfizer (PFE) or Novartis (NVS) could see "an attractive target to plunder," Fernandez tells investors. He keeps an Outperform rating and $36 price target on AstraZeneca ADRs.
TEVA Teva
$32.78

-0.41 (-1.24%)

06/27/17
WELS
06/27/17
NO CHANGE
WELS
Market Perform
Teva TV-45070 trial miss a 'modest disappointment,' says Wells Fargo
Wells Fargo analyst David Maris said TV-45070 has not been a focus for Teva (TEVA) investors, but he still views the news that the company and partner Xenon Pharmaceuticals' (XENE) Phase 2 trial in post-herpetic neuralgia missed its primary endpoint as a "modest disappointment" given the need for Teva's pipeline to offset the tough generic market and the eventual competition for Copaxone. Maris keeps a Market Perform rating on Teva.
07/05/17
OPCO
07/05/17
NO CHANGE
Target $70
OPCO
Outperform
Neurocrine Ingrezza 'holds steady' after competitor data, says Oppenheimer
Oppenheimer analyst Jay Olson notes that Teva's (TEVA) Austedo could become a competitor to Neurocrine's (NBIX) Ingrezza with a PDUFA date for the tardive dyskinesia indication on August 30, 2017. However, the analyst sees Ingrezza as well positioned and reiterates an Outperform rating and $70 price target on Neurocrine's shares. A key factor to follow beyond the short trials will be real-life performance considering the number needed to treat to observe a 50% AIMS improvement was 5 for Austedo and 4 for Ingrezza, he contends.

TODAY'S FREE FLY STORIES

SPWR

SunPower

$6.89

-0.09 (-1.29%)

, SUNEQ

SunEdison

$0.00

(0.00%)

21:08
08/14/18
08/14
21:08
08/14/18
21:08
Periodicals
China lodges WTO complaint about U.S. solar tariffs, Reuters says »

China Commerce Ministry…

SPWR

SunPower

$6.89

-0.09 (-1.29%)

SUNEQ

SunEdison

$0.00

(0.00%)

CSIQ

Canadian Solar

$13.33

-0.27 (-1.99%)

JASO

JA Solar

$0.00

(0.00%)

TSL

Trina Solar

$0.00

(0.00%)

FSLR

First Solar

$52.01

-0.48 (-0.91%)

SCTY

Bought by TSLA

$0.00

(0.00%)

YGE

Yingli Green Energy

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

GS

Goldman Sachs

$229.53

2.7 (1.19%)

20:39
08/14/18
08/14
20:39
08/14/18
20:39
Periodicals
Judge allows Goldman shareholders to pursue 2008 CDO class action, Reuters says »

U.S. District Court judge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$41.87

1.79 (4.47%)

, PFGC

Performance Food Group

$37.60

0.7 (1.90%)

20:25
08/14/18
08/14
20:25
08/14/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

M

Macy's

$41.87

1.79 (4.47%)

PFGC

Performance Food Group

$37.60

0.7 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 17

    Sep

FAF

First American

$56.46

0.04 (0.07%)

20:16
08/14/18
08/14
20:16
08/14/18
20:16
Hot Stocks
First American raises quarterly dividend by 11% to 42c per share »

The cash dividend is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BAS

Basic Energy

$8.61

-0.11 (-1.26%)

20:12
08/14/18
08/14
20:12
08/14/18
20:12
Hot Stocks
Basic Energy names David Schorlemer as new CFO »

Basic Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

MRT

MedEquities Realty Trust

$10.00

0.16 (1.63%)

19:45
08/14/18
08/14
19:45
08/14/18
19:45
Periodicals
MedEquities Realty Trust exploring a sale, Bloomberg reports »

MedEquities Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.50

0.04 (0.42%)

19:26
08/14/18
08/14
19:26
08/14/18
19:26
Periodicals
Ford plans to invest $740M to revamp Detroit station, other sites, Reuters says »

Ford said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 31

    Aug

PETQ

PetIQ

$28.26

1 (3.67%)

, PRSP

Perspecta

$21.64

-0.31 (-1.41%)

19:00
08/14/18
08/14
19:00
08/14/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: PetIQ…

PETQ

PetIQ

$28.26

1 (3.67%)

PRSP

Perspecta

$21.64

-0.31 (-1.41%)

FENG

Phoenix New Media

$4.12

-0.055 (-1.32%)

EGN

Energen

$73.15

1.76 (2.47%)

FANG

Diamondback Energy

$133.75

1.84 (1.39%)

ADNT

Adient

$42.65

0.19 (0.45%)

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

TEVA

Teva

$22.12

0.17 (0.77%)

CASA

Casa Systems

$15.62

-0.17 (-1.08%)

A

Agilent

$66.72

0.77 (1.17%)

CREE

Cree

$50.17

-0.11 (-0.22%)

VRAY

ViewRay

$9.89

-0.01 (-0.10%)

CRZO

Carrizo Oil & Gas

$24.31

0.62 (2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 19

    Aug

  • 21

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 16

    Sep

  • 15

    Aug

  • 15

    Aug

AAP

Advance Auto Parts

$156.01

11.22 (7.75%)

18:47
08/14/18
08/14
18:47
08/14/18
18:47
Upgrade
Advance Auto Parts rating change at Citi »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

SPHS

Sophiris Bio

$2.74

0.13 (4.98%)

18:37
08/14/18
08/14
18:37
08/14/18
18:37
Recommendations
Sophiris Bio analyst commentary at Piper Jaffray »

Sophiris Bio topsalycin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$52.87

0.65 (1.24%)

, GOOG

Alphabet

$1,241.95

6.85 (0.55%)

18:30
08/14/18
08/14
18:30
08/14/18
18:30
Hot Stocks
Verizon to partner with YouTube TV for 5G residential broadband package »

Verizon (VZ) announced it…

VZ

Verizon

$52.87

0.65 (1.24%)

GOOG

Alphabet

$1,241.95

6.85 (0.55%)

GOOGL

Alphabet Class A

$1,258.15

9.39 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

NVDA

Nvidia

$261.47

5.39 (2.10%)

18:27
08/14/18
08/14
18:27
08/14/18
18:27
Upgrade
Nvidia rating change at Wells Fargo »

Nvidia double-upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ORCL

Oracle

$48.23

0.21 (0.44%)

, RMNI

Rimini Street

$6.01

0.11 (1.86%)

18:26
08/14/18
08/14
18:26
08/14/18
18:26
Hot Stocks
Court grants Oracle's motion for permanent injunction against Rimini Street »

For the second time, a…

ORCL

Oracle

$48.23

0.21 (0.44%)

RMNI

Rimini Street

$6.01

0.11 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$261.47

5.39 (2.10%)

18:22
08/14/18
08/14
18:22
08/14/18
18:22
Upgrade
Nvidia rating change at Wells Fargo »

Nvidia double-upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

CVS

CVS Health

$71.39

1.88 (2.70%)

18:20
08/14/18
08/14
18:20
08/14/18
18:20
Hot Stocks
CVS Health says 'actively working' with Ohio Managed Medicaid clients »

"CVS Health is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

VRAY

ViewRay

$9.89

-0.01 (-0.10%)

18:18
08/14/18
08/14
18:18
08/14/18
18:18
Syndicate
ViewRay $125M Spot Secondary; price range $9.25-$9.50 »

Morgan Stanley, Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 04

    Sep

CRZO

Carrizo Oil & Gas

$24.31

0.62 (2.62%)

18:16
08/14/18
08/14
18:16
08/14/18
18:16
Syndicate
Carrizo Oil & Gas 9.5M share Spot Secondary; price range $22.90-$23.50 »

Citi and Goldman Sachs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 15

    Aug

WTW

Weight Watchers

$77.39

1.8 (2.38%)

18:12
08/14/18
08/14
18:12
08/14/18
18:12
Syndicate
Weight Watchers 6M share Block Trade; price range $76.00-$77.00 »

Morgan Stanley is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

, PAY

Verifone

$23.00

-0.02 (-0.09%)

18:05
08/14/18
08/14
18:05
08/14/18
18:05
Hot Stocks
S&P announces changes to S&P MidCap 400 index »

S&P Dow Jones Indices…

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

PAY

Verifone

$23.00

-0.02 (-0.09%)

ADNT

Adient

$42.65

0.19 (0.45%)

DCT

DCT Industrial

$65.28

-0.34 (-0.52%)

PLD

Prologis

$64.05

-0.38 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$116.73

0.7 (0.60%)

18:00
08/14/18
08/14
18:00
08/14/18
18:00
Hot Stocks
Celanese to increase price of acetate flake by 50c/kg »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

GDDY

GoDaddy

$75.81

0.52 (0.69%)

17:43
08/14/18
08/14
17:43
08/14/18
17:43
Syndicate
GoDaddy files to sell 10,398,942 shares of Class A common stock »

Selling stockholders are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAG

MAG Silver

$8.64

0.07 (0.82%)

17:41
08/14/18
08/14
17:41
08/14/18
17:41
Earnings
MAG Silver reports Q2 EPS (3c), consensus (2c) »

Reports cash and cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$113.07

0.09 (0.08%)

17:39
08/14/18
08/14
17:39
08/14/18
17:39
Hot Stocks
SPDR Gold Trust holdings fall to 776.65MT from 784.60MT »

This is the 2nd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNES

SenesTech

$0.95

-0.0779 (-7.60%)

17:36
08/14/18
08/14
17:36
08/14/18
17:36
Syndicate
Breaking Syndicate news story on SenesTech »

SenesTech files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXWL

Maxwell

$3.98

0.59 (17.40%)

17:36
08/14/18
08/14
17:36
08/14/18
17:36
Hot Stocks
Breaking Hot Stocks news story on Maxwell »

VIEX Capital Advisors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.